A Republican representative objects to a study he said is politically partisan.
Daily News Roundup
A Republican representative objects to a study he said is politically partisan.
The President asks large agencies to make all government-funded research publicly available within a year of publication.
The first human trial of a treatment using induced pluripotent stem cells has received conditional approval from an institutional review board in Japan.
Some of the 200 or so human embryonic stem cell lines approved for federal funding may have been derived from sperm or eggs of unconsenting donors.
A new study disputes findings of a 2011 analysis suggesting that black researchers are funded less than their equally qualified white peers.
Researchers uncover more evidence that reprogrammed stem cells are not attacked by the immune system, suggesting they may one day serve as effective therapies.
After a year-long voluntary moratorium to discuss regulations and safety measures, scientists are set to resume controversial H5N1 research.
A National Institutes of Health working group urges the agency to send most of its chimpanzees to a national sanctuary and halt half of the experiments involving such animals.
Long-term, life, and disability insurers may still be able to deny coverage to patients with a genetic disease, under current nondiscrimination legislation.
The US Food and Drug Administration approves the first flu vaccine made from recombinant proteins rather than a weakened virus.